Moderate continuous or high intensity interval exercise in heart failure with reduced ejection fraction: Differences between ischemic and non-ischemic etiology

被引:0
|
作者
Halle, Martin [1 ,2 ,16 ]
Prescott, Eva [3 ]
Craenenbroeck, Emeline M. Van [4 ,5 ]
Beckers, Paul [4 ,5 ]
Videm, Vibeke [6 ,7 ]
Karlsen, Trine [8 ,9 ]
Feiereisen, Patrick [10 ]
Winzer, Ephraim B. [11 ]
Mangner, Norman [11 ]
Snoer, Martin [3 ,15 ]
Christle, Jeffrey W. [1 ,12 ]
Dalen, Havard [8 ,10 ,13 ,14 ]
Stoylen, Asbjorn [8 ,10 ,13 ]
Esefeld, Katrin [1 ,2 ]
Heitkamp, Melanie [1 ]
Spanier, Bianca [1 ]
Linke, Axel
Ellingsen, Oyvind [10 ,13 ]
Delagardelle, Charles [10 ]
机构
[1] Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Prevent & Sports Med, Munich, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany
[3] Univ Copenhagen, Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark
[4] Univ Antwerp, GENCOR Dept, Res Grp Cardiovasc Dis, Antwerp, Belgium
[5] Antwerp Univ Hosp, Dept Cardiol, Edegem, Belgium
[6] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, NTNU, Trondheim, Norway
[7] St Olavs Univ Hosp, Dept Immunol & Transfus Med, Trondheim, Norway
[8] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Cardiac Exercise Res Grp CERG, Trondheim, Norway
[9] Nord Univ, Fac Nursing & Hlth Sci, Bodo, Norway
[10] Hosp Ctr Luxembourg, Dept Cardiol, Luxembourg, Luxembourg
[11] Tech Univ Dresden, Heart Ctr Dresden, Univ Hosp, Dept Internal Med & Cardiol, Dresden, Germany
[12] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA USA
[13] St Olavs Univ Hosp, Clin Cardiol, Trondheim, Norway
[14] Levanger Hosp, Nord Trondelag Hosp Trust, Dept Med & Rehabil, Levanger, Norway
[15] Zeeland Univ Hosp, Dept Dermatol, Roskilde, Denmark
[16] Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Prevent & Sports Med, Munich, Germany
来源
AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE | 2022年 / 22卷
关键词
Exercise intensity; Training; HIIT; Heart failure; Etiology; AEROBIC EXERCISE; ESC GUIDELINES; SUDDEN-DEATH; CARDIOMYOPATHY; DISEASE; HF; DEFIBRILLATOR; RISK;
D O I
10.1016/j.ahjo.2022.100202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise for heart failure (HF) with reduced ejection fraction (HFrEF) is recommended by guidelines, but exercise mode and intensities are not differentiated between HF etiologies. We, therefore, investigated the effect of moderate or high intensity exercise on left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF) and maximal exercise capacity (peak VO2) in patients with ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM).Methods: The Study of Myocardial Recovery after Exercise Training in Heart Failure (SMARTEX-HF) consecutively enrolled 231 patients with HFrEF (LVEF <= 35 %, NYHA II-III) in a 12-weeks supervised exercise program. Patients were stratified for HFrEF etiology (ICM versus NICM) and randomly assigned (1:1:1) to supervised exercise thrice weekly: a) moderate continuous training (MCT) at 60-70 % of peak heart rate (HR), b) high intensity interval training (HIIIT) at 90-95 % peak HR, or c) recommendation of regular exercise (RRE) according to guidelines. LVEDD, LVEF and peak VO2 were assessed at baseline, after 12 and 52 weeks.Results: 215 patients completed the intervention. ICM (59 %; n = 126) compared to NICM patients (41 %; n = 89) had significantly lower peak VO2 values at baseline and after 12 weeks (difference in peak VO2 2.2 mL/(kg*min); p < 0.0005) without differences between time points (p = 0.11) or training groups (p = 0.15). Etiology did not influence changes of LVEDD or LVEF (p = 0.30; p = 0.12), even when adjusting for sex, age and smoking status (p = 0.54; p = 0.12). Similar findings were observed after 52 weeks.Conclusions: Etiology of HFrEF did not influence the effects of moderate or high intensity exercise on cardiac dimensions, systolic function or exercise capacity.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis
    Canepa, Marco
    Anastasia, Gianluca
    Ameri, Pietro
    Vergallo, Rocco
    O'Connor, Christopher M.
    Sinagra, Gianfranco
    Porto, Italo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 134 : 51 - 58
  • [12] Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction- Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
    Tyminska, Agata
    Ozieranski, Krzysztof
    Balsam, Pawel
    Maciejewski, Cezary
    Wancerz, Anna
    Brociek, Emil
    Marchel, Michal
    Crespo-Leiro, Maria G.
    Maggioni, Aldo P.
    Drozdz, Jaroslaw
    Opolski, Grzegorz
    Grabowski, Marcin
    Kaplon-Cieslicka, Agnieszka
    BIOLOGY-BASEL, 2022, 11 (02):
  • [13] Determinants of Exercise Tolerance in Patients With Non-Ischemic Heart Failure and Mid-Range Ejection Fraction as Assessed by Cardiopulmonary Exercise Testing
    Harada, Ken
    Mamiya, Kumiko
    Suzuki, Hitomi
    Matsunaga, Shun
    Nishikawa, Yoshinori
    Harada, Kazuhiro
    Nagao, Tomoyuki
    Shinoda, Norihiro
    Kato, Masataka
    Marui, Nobuyuki
    Amano, Tetsuya
    Matsubara, Tatsuaki
    Murohara, Toyoaki
    CIRCULATION, 2018, 138
  • [14] Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction
    Gasior, Pawel
    Wojakowski, Wojciech
    Kedhi, Elvin
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (05) : 401 - 409
  • [15] Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction
    Pawel Gasior
    Wojciech Wojakowski
    Elvin Kedhi
    Current Cardiology Reports, 2023, 25 : 401 - 409
  • [16] Primary prevention implantable cardioverter defibrillator in patients with reduced ejection fraction: for ischemic or non-ischemic cardiomyopathy or both?
    Barakat, Amr F.
    Mahmoud, Ahmed N.
    Elgendy, Islam Y.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (09) : 2749 - 2751
  • [17] Clinical Predictors of Response to Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction due to Non-Ischemic Cardiomyopathy
    Ather, Sameer
    Bajaj, Navkaranbir S.
    Bhatia, Vikas
    Morgan, Charity
    Prabhu, Sumanth D.
    Deedwania, Prakash
    Fonarow, Gregg C.
    Kheirbek, Raya
    Aronow, Wilbert
    Anker, Stefan
    Fletcher, Ross
    Ahmed, Ali
    CIRCULATION, 2014, 130
  • [18] Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction
    Mercer, Ben N.
    Koshy, Aaron
    Drozd, Michael
    Walker, Andrew M. N.
    Patel, Peysh A.
    Kearney, Lorraine
    Gierula, John
    Paton, Maria F.
    Lowry, Judith E.
    Kearney, Mark T.
    Cubbon, Richard M.
    Witte, Klaus K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (20):
  • [19] Association Between Heart Failure With Preserved Ejection Fraction and Ischemic Stroke
    Omran, Setareh Salehi
    Merkler, Alexander E.
    Diaz, Ivan
    Azary, Saeedeh
    Goyal, Parag
    Navi, Babak
    Kamel, Hooman
    STROKE, 2018, 49
  • [20] Metabolic profiles in heart failure due to non-ischemic cardiomyopathy at rest and under exercise
    Mueller-Hennessen, Matthias
    Sigl, Johanna
    Fuhrmann, Jens C.
    Witt, Henning
    Reszka, Regina
    Schmitz, Oliver
    Kastler, Juergen
    Fischer, Jenny J.
    Mueller, Oliver J.
    Giannitsis, Evangelos
    Weis, Tanja
    Frey, Norbert
    Katus, Hugo A.
    ESC HEART FAILURE, 2017, 4 (02): : 178 - 189